Track papers across labs, topics, and trends.
Search papers, labs, and topics across Lattice.
1
0
0
2
The combination of immune-modulating, non-ablative doses of radiation therapy with ipilimumab and nivolumab has selective clinical activity in refractory MSS CRC, with responses concentrated primarily in patients without active liver metastases.